These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
615 related articles for article (PubMed ID: 33897885)
1. The PSMD14 inhibitor Thiolutin as a novel therapeutic approach for esophageal squamous cell carcinoma through facilitating SNAIL degradation. Jing C; Li X; Zhou M; Zhang S; Lai Q; Liu D; Ye B; Li L; Wu Y; Li H; Yue K; Chen P; Yao X; Wu Y; Duan Y; Wang X Theranostics; 2021; 11(12):5847-5862. PubMed ID: 33897885 [TBL] [Abstract][Full Text] [Related]
2. Deubiquitinating enzyme PSMD14 promotes tumor metastasis through stabilizing SNAIL in human esophageal squamous cell carcinoma. Zhu R; Liu Y; Zhou H; Li L; Li Y; Ding F; Cao X; Liu Z Cancer Lett; 2018 Apr; 418():125-134. PubMed ID: 29331416 [TBL] [Abstract][Full Text] [Related]
3. Blockade of deubiquitinating enzyme PSMD14 overcomes chemoresistance in head and neck squamous cell carcinoma by antagonizing E2F1/Akt/SOX2-mediated stemness. Jing C; Duan Y; Zhou M; Yue K; Zhuo S; Li X; Liu D; Ye B; Lai Q; Li L; Yao X; Wei H; Zhang W; Wu Y; Wang X Theranostics; 2021; 11(6):2655-2669. PubMed ID: 33456565 [TBL] [Abstract][Full Text] [Related]
4. EIF3H promotes aggressiveness of esophageal squamous cell carcinoma by modulating Snail stability. Guo X; Zhu R; Luo A; Zhou H; Ding F; Yang H; Liu Z J Exp Clin Cancer Res; 2020 Aug; 39(1):175. PubMed ID: 32867821 [TBL] [Abstract][Full Text] [Related]
5. Long non‑coding RNA MEG3 suppresses epithelial‑to‑mesenchymal transition by inhibiting the PSAT1‑dependent GSK‑3β/Snail signaling pathway in esophageal squamous cell carcinoma. Li MK; Liu LX; Zhang WY; Zhan HL; Chen RP; Feng JL; Wu LF Oncol Rep; 2020 Nov; 44(5):2130-2142. PubMed ID: 32901893 [TBL] [Abstract][Full Text] [Related]
6. 3,3'-Diindolylmethane modulates aryl hydrocarbon receptor of esophageal squamous cell carcinoma to reverse epithelial-mesenchymal transition through repressing RhoA/ROCK1-mediated COX2/PGE Zhu P; Yu H; Zhou K; Bai Y; Qi R; Zhang S J Exp Clin Cancer Res; 2020 Jun; 39(1):113. PubMed ID: 32546278 [TBL] [Abstract][Full Text] [Related]
7. USP26 promotes esophageal squamous cell carcinoma metastasis through stabilizing Snail. Li L; Zhou H; Zhu R; Liu Z Cancer Lett; 2019 Apr; 448():52-60. PubMed ID: 30763716 [TBL] [Abstract][Full Text] [Related]
8. BACH1 promotes the progression of esophageal squamous cell carcinoma by inducing the epithelial-mesenchymal transition and angiogenesis. Zhao Y; Gao J; Xie X; Nan P; Liu F; Sun Y; Zhao X Cancer Med; 2021 May; 10(10):3413-3426. PubMed ID: 33932125 [TBL] [Abstract][Full Text] [Related]
9. RIT1 suppresses esophageal squamous cell carcinoma growth and metastasis and predicts good prognosis. Feng YF; Lei YY; Lu JB; Xi SY; Zhang Y; Huang QT; Wu QL; Wang F Cell Death Dis; 2018 Oct; 9(11):1085. PubMed ID: 30348939 [TBL] [Abstract][Full Text] [Related]
10. Luteolin enhances drug chemosensitivity by downregulating the FAK/PI3K/AKT pathway in paclitaxel‑resistant esophageal squamous cell carcinoma. Yang Z; Liu H; Song Y; Gao N; Gao P; Hui Y; Li Y; Fan T Int J Mol Med; 2024 Sep; 54(3):. PubMed ID: 38994756 [TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4. Yang C; Shen S; Zheng X; Ye K; Ge H; Sun Y; Lu Y FASEB J; 2020 May; 34(5):6055-6069. PubMed ID: 32239565 [TBL] [Abstract][Full Text] [Related]
12. RASSF6-TRIM16 axis promotes cell proliferation, migration and invasion in esophageal squamous cell carcinoma. Zheng L; Zhao Z; Rong L; Xue L; Song Y J Genet Genomics; 2019 Oct; 46(10):477-488. PubMed ID: 31812473 [TBL] [Abstract][Full Text] [Related]
13. OTUB1 promotes esophageal squamous cell carcinoma metastasis through modulating Snail stability. Zhou H; Liu Y; Zhu R; Ding F; Cao X; Lin D; Liu Z Oncogene; 2018 Jun; 37(25):3356-3368. PubMed ID: 29559747 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA SNHG12 induces proliferation, migration, epithelial-mesenchymal transition, and stemness of esophageal squamous cell carcinoma cells via post-transcriptional regulation of BMI1 and CTNNB1. Wu D; He X; Wang W; Hu X; Wang K; Wang M Mol Oncol; 2020 Sep; 14(9):2332-2351. PubMed ID: 32239639 [TBL] [Abstract][Full Text] [Related]
15. SPSB3 targets SNAIL for degradation in GSK-3β phosphorylation-dependent manner and regulates metastasis. Liu Y; Zhou H; Zhu R; Ding F; Li Y; Cao X; Liu Z Oncogene; 2018 Feb; 37(6):768-776. PubMed ID: 29059170 [TBL] [Abstract][Full Text] [Related]
16. The deubiquitinating enzyme PSMD14 facilitates tumor growth and chemoresistance through stabilizing the ALK2 receptor in the initiation of BMP6 signaling pathway. Seo D; Jung SM; Park JS; Lee J; Ha J; Kim M; Park SH EBioMedicine; 2019 Nov; 49():55-71. PubMed ID: 31685442 [TBL] [Abstract][Full Text] [Related]
17. TIM-3 promotes the metastasis of esophageal squamous cell carcinoma by targeting epithelial-mesenchymal transition via the Akt/GSK-3β/Snail signaling pathway. Shan B; Man H; Liu J; Wang L; Zhu T; Ma M; Xv Z; Chen X; Yang X; Li P Oncol Rep; 2016 Sep; 36(3):1551-61. PubMed ID: 27430162 [TBL] [Abstract][Full Text] [Related]
18. MTA1 promotes tumorigenesis and development of esophageal squamous cell carcinoma via activating the MEK/ERK/p90RSK signaling pathway. Nan P; Wang T; Li C; Li H; Wang J; Zhang J; Dou N; Zhan Q; Ma F; Wang H; Qian H Carcinogenesis; 2020 Sep; 41(9):1263-1272. PubMed ID: 31783401 [TBL] [Abstract][Full Text] [Related]
19. PURα mediates epithelial-mesenchymal transition to promote esophageal squamous cell carcinoma progression by regulating Snail2. Gao J; Tian L; Sun Y; Li W; Zhao L; Sun Y; Jing Z; Zhou L; Liu F; Zhao X Cancer Lett; 2021 Feb; 498():98-110. PubMed ID: 33144099 [TBL] [Abstract][Full Text] [Related]
20. Circular RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p. Chen X; Jiang J; Zhao Y; Wang X; Zhang C; Zhuan L; Zhang D; Zheng Y J Exp Clin Cancer Res; 2020 Jul; 39(1):133. PubMed ID: 32653032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]